Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446)

Soo Jin Na; Jong Chan Youn; Hye Sun Lee; Soyoung Jeon; Hae Young Lee; Hyun Jai Cho; Jin Oh Choi; Eun Seok Jeon; Sang Eun Lee; Min Seok Kim; Jae Joong Kim; Kyung Kuk Hwang; Myeong Chan Cho; Shung Chull Chae; Seok Min Kang; Dong Ju Choi; Byung Su Yoo; Kye Hun Kim; Byung Hee Oh; Sang Hong Baek

doi:10.3389/fcvm.2022.888829

Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446)

Soo Jin Na
, Jong Chan Youn
, Hye Sun Lee
, Soyoung Jeon
, Hae Young Lee
, Hyun Jai Cho
, Jin Oh Choi
, Eun Seok Jeon
, Sang Eun Lee
, Min Seok Kim
, Jae Joong Kim
, Kyung Kuk Hwang
, Myeong Chan Cho
, Shung Chull Chae
, Seok Min Kang
, Dong Ju Choi
, Byung Su Yoo
, Kye Hun Kim
, Byung Hee Oh
, Sang Hong Baek

Department of Internal Medicine

Sungkyunkwan University
The Catholic University of Korea
Yonsei University
Seoul National University
University of Ulsan
Chungbuk National University
Kyungpook National University
Yonsei University Mirae Campus
Chonnam National University
Mediplex Sejong Hospital
Catholic Univ. of Korea Coll. Med.

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Abstract

In the original article, there was an error. An author name was incorrectly spelled as “Kye Hoon Kim.” The correct spelling is “Kye Hun Kim.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original language	English
Article number	888829
Journal	Frontiers in Cardiovascular Medicine
Volume	9
DOIs	https://doi.org/10.3389/fcvm.2022.888829
State	Published - 4 Apr 2022

Bibliographical note

Publisher Copyright:
Copyright © 2022, Na, Youn, Lee, Jeon, Lee, Cho, Choi, Jeon, Lee, Kim, Kim, Hwang, Cho, Chae, Kang, Choi, Yoo, Kim, Oh and Baek.

Keywords

acute heart failure syndrome
drug therapy
mineralocorticoid receptor antagonists
outcome
spironolactone

Access to Document

10.3389/fcvm.2022.888829

Fingerprint

Dive into the research topics of 'Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446)'. Together they form a unique fingerprint.

Cite this

Na, S. J., Youn, J. C., Lee, H. S., Jeon, S., Lee, H. Y., Cho, H. J., Choi, J. O., Jeon, E. S., Lee, S. E., Kim, M. S., Kim, J. J., Hwang, K. K., Cho, M. C., Chae, S. C., Kang, S. M., Choi, D. J., Yoo, B. S., Kim, K. H., Oh, B. H., & Baek, S. H. (2022). Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446). Frontiers in Cardiovascular Medicine, 9, Article 888829. https://doi.org/10.3389/fcvm.2022.888829

@article{904813f7577e4b62b933187ee3fbde25,

title = "Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446)",

abstract = "In the original article, there was an error. An author name was incorrectly spelled as “Kye Hoon Kim.” The correct spelling is “Kye Hun Kim.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.",

keywords = "acute heart failure syndrome, drug therapy, mineralocorticoid receptor antagonists, outcome, spironolactone",

author = "Na, \{Soo Jin\} and Youn, \{Jong Chan\} and Lee, \{Hye Sun\} and Soyoung Jeon and Lee, \{Hae Young\} and Cho, \{Hyun Jai\} and Choi, \{Jin Oh\} and Jeon, \{Eun Seok\} and Lee, \{Sang Eun\} and Kim, \{Min Seok\} and Kim, \{Jae Joong\} and Hwang, \{Kyung Kuk\} and Cho, \{Myeong Chan\} and Chae, \{Shung Chull\} and Kang, \{Seok Min\} and Choi, \{Dong Ju\} and Yoo, \{Byung Su\} and Kim, \{Kye Hun\} and Oh, \{Byung Hee\} and Baek, \{Sang Hong\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2022, Na, Youn, Lee, Jeon, Lee, Cho, Choi, Jeon, Lee, Kim, Kim, Hwang, Cho, Chae, Kang, Choi, Yoo, Kim, Oh and Baek.",

year = "2022",

month = apr,

day = "4",

doi = "10.3389/fcvm.2022.888829",

language = "English",

volume = "9",

journal = "Frontiers in Cardiovascular Medicine",

issn = "2297-055X",

publisher = "Frontiers Media SA",

}

Na, SJ, Youn, JC, Lee, HS, Jeon, S, Lee, HY, Cho, HJ, Choi, JO, Jeon, ES, Lee, SE, Kim, MS, Kim, JJ, Hwang, KK, Cho, MC, Chae, SC, Kang, SM, Choi, DJ, Yoo, BS, Kim, KH, Oh, BH & Baek, SH 2022, 'Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446)', Frontiers in Cardiovascular Medicine, vol. 9, 888829. https://doi.org/10.3389/fcvm.2022.888829

Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446). / Na, Soo Jin; Youn, Jong Chan; Lee, Hye Sun et al.
In: Frontiers in Cardiovascular Medicine, Vol. 9, 888829, 04.04.2022.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum

T2 - The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446)

AU - Na, Soo Jin

AU - Youn, Jong Chan

AU - Lee, Hye Sun

AU - Jeon, Soyoung

AU - Lee, Hae Young

AU - Cho, Hyun Jai

AU - Choi, Jin Oh

AU - Jeon, Eun Seok

AU - Lee, Sang Eun

AU - Kim, Min Seok

AU - Kim, Jae Joong

AU - Hwang, Kyung Kuk

AU - Cho, Myeong Chan

AU - Chae, Shung Chull

AU - Kang, Seok Min

AU - Choi, Dong Ju

AU - Yoo, Byung Su

AU - Kim, Kye Hun

AU - Oh, Byung Hee

AU - Baek, Sang Hong

PY - 2022/4/4

Y1 - 2022/4/4

N2 - In the original article, there was an error. An author name was incorrectly spelled as “Kye Hoon Kim.” The correct spelling is “Kye Hun Kim.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

AB - In the original article, there was an error. An author name was incorrectly spelled as “Kye Hoon Kim.” The correct spelling is “Kye Hun Kim.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

KW - acute heart failure syndrome

KW - drug therapy

KW - mineralocorticoid receptor antagonists

KW - outcome

KW - spironolactone

UR - https://www.scopus.com/pages/publications/85138898672

U2 - 10.3389/fcvm.2022.888829

DO - 10.3389/fcvm.2022.888829

M3 - Comment/debate

AN - SCOPUS:85138898672

SN - 2297-055X

VL - 9

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

M1 - 888829

ER -

Na SJ, Youn JC, Lee HS, Jeon S, Lee HY, Cho HJ et al. Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446). Frontiers in Cardiovascular Medicine. 2022 Apr 4;9:888829. doi: 10.3389/fcvm.2022.888829

Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study (Front. Cardiovasc. Med., (2022), 9, (791446), 10.3389/fcvm.2022.791446)

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this